RIPE-KG · Version 1.1.0 · Resource

ripekg:work/RIPEW52262D23452D141B

https://w3id.org/ripe/ripe-kg/work/RIPEW52262D23452D141B
SubjectPredicateObject
ripekg:work/10.1111%2F1756-185x.13688Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double‐blind, controlled trial http://purl.org/spar/cito/cites ripekg:work/RIPEW52262D23452D141BA novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebocontrolled, two-dose, three-Arm, and parallel-group study
ripekg:work/RIPEW52262D23452D141BA novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebocontrolled, two-dose, three-Arm, and parallel-group study dcterms:title A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebocontrolled, two-dose, three-Arm, and parallel-group study
ripekg:work/RIPEW52262D23452D141BA novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebocontrolled, two-dose, three-Arm, and parallel-group study rdf:type node1
ripekg:work/RIPEW52262D23452D141BA novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebocontrolled, two-dose, three-Arm, and parallel-group study rdf:type http://purl.org/spar/fabio/Work
ripekg:work/RIPEW52262D23452D141BA novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebocontrolled, two-dose, three-Arm, and parallel-group study rdf:type rdfs:Resource
ripekg:work/RIPEW52262D23452D141BA novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebocontrolled, two-dose, three-Arm, and parallel-group study rdf:type owl:Thing
ripekg:work/RIPEW52262D23452D141BA novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebocontrolled, two-dose, three-Arm, and parallel-group study rdf:type prov:Entity
ripekg:work/RIPEW52262D23452D141BA novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebocontrolled, two-dose, three-Arm, and parallel-group study rdf:type ripe:WorkWork